No change in calculated creatinine clearance after tenofovir initiation among Thai patients
Author(s) -
Angèle GayetAgeron,
Jintanat Ananworanich,
Thidarat Jupimai,
Ploenchan Chetchotisakd,
Wisit Prasithsirikul,
Sasiwimol Ubolyam,
Michelle Le Braz,
Kiat Ruxrungtham,
James F. Rooney,
Bernard Hirschel
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm064
Subject(s) - renal function , medicine , nephrotoxicity , creatinine , tenofovir , lamivudine , population , urology , ritonavir , human immunodeficiency virus (hiv) , antiretroviral therapy , kidney , viral load , hepatitis b virus , virus , environmental health , family medicine , virology
Thai patients have a lower average body weight than patients from western Europe or the USA. Tenofovir is largely prescribed at the standard dosage of 300 mg once daily: therefore, the per kilogram dose is higher in Thailand than in the USA. We asked the question whether this higher per kilogram dose was associated with more nephrotoxicity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom